BlackRock Health Sciences Trust
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +0.3% | +0.0% | -1.9% | +0.0% | +4.9% | 0.0% | +23.9% | -31.8% | +7.9% | +0.8% | |
| – | -99.9% | +127,920.6% | -100.0% | +267,370.8% | -100.0% | +645,278.1% | +0.0% | +670.6% | -93.4% | +204.2% | +317.5% | |
| – | +0.0% | -80.6% | +0.0% | -11.9% | +0.0% | +113.3% | +0.0% | +6,163.3% | -44.8% | -98.6% | -34.1% | |
| – | +0.0% | -80.6% | +0.0% | -11.9% | +0.0% | +113.3% | +0.0% | +2,331,664.8% | -99.9% | +12,377.3% | +301.5% | |
| – | +0.0% | +65.1% | +2.1% | -60.5% | +0.0% | +100.6% | +0.0% | -62.2% | +42.0% | -74.8% | +501.7% | |
| – | – | – | +0.0% | -100.0% | – | – | +0.0% | – | – | – | – | |
| – | +0.0% | +77.5% | +0.0% | -24.4% | +0.0% | +13.1% | +0.0% | -33.1% | +240.6% | -91.1% | +72.7% | |
| – | -96.1% | +4,416.9% | -95.0% | +1,409.0% | -99.2% | +14,755.5% | -98.1% | – | – | – | – | |
| – | -99.6% | +90,159.7% | -96.4% | -36.9% | +0.0% | +1,595.4% | -98.8% | +64.4% | +6,577.5% | – | – | |
| – | +0.0% | +53.5% | +47.5% | – | – | – | – | +185.4% | +2,799.4% | -98.5% | +660.9% | |
| – | +0.0% | -0.5% | +0.0% | -1.5% | +0.0% | +4.8% | +0.0% | +24.7% | -33.9% | +11.8% | +0.6% | |
| – | +0.0% | -3.7% | +0.0% | +0.6% | +0.0% | +16.5% | +0.0% | -187.4% | – | +49.5% | +1.5% | |
| – | +0.0% | +0.6% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -4.9% | -2.5% | +0.0% | +0.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.